NCT06623084View on ClinicalTrials.gov

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

Not yet recruitingOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

March 12, 2025

Study Completion Date

December 24, 2025

Conditions
Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosisControl Condition
Interventions
OTHER

Platelets characterization

To identify platelet features that correlate with liver disease progression and to study the mechanistic relationship between gut dysbiosis, metabolome composition, inflammation, and platelet activation in chronic liver disease.

All Listed Sponsors
collaborator

University of Rome Tor Vergata

OTHER

collaborator

Catholic University of the Sacred Heart

OTHER

lead

Stefania Basili

OTHER

NCT06623084 - Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS) | Biotech Hunter | Biotech Hunter